Literature DB >> 26906089

Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.

Lance M Hellman1, Liusong Yin2, Yuan Wang1, Sydney J Blevins1, Timothy P Riley1, Orrin S Belden1, Timothy T Spear3, Michael I Nishimura3, Lawrence J Stern4, Brian M Baker5.   

Abstract

Measurements of thermal stability by circular dichroism (CD) spectroscopy have been widely used to assess the binding of peptides to MHC proteins, particularly within the structural immunology community. Although thermal stability assays offer advantages over other approaches such as IC50 measurements, CD-based stability measurements are hindered by large sample requirements and low throughput. Here we demonstrate that an alternative approach based on differential scanning fluorimetry (DSF) yields results comparable to those based on CD for both class I and class II complexes. As they require much less sample, DSF-based measurements reduce demands on protein production strategies and are amenable for high throughput studies. DSF can thus not only replace CD as a means to assess peptide/MHC thermal stability, but can complement other peptide-MHC binding assays used in screening, epitope discovery, and vaccine design. Due to the physical process probed, DSF can also uncover complexities not observed with other techniques. Lastly, we show that DSF can also be used to assess peptide/MHC kinetic stability, allowing for a single experimental setup to probe both binding equilibria and kinetics.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Binding affinity; Differential scanning fluorimetry; Kinetic stability; MHC protein; Thermal stability

Mesh:

Substances:

Year:  2016        PMID: 26906089      PMCID: PMC4837003          DOI: 10.1016/j.jim.2016.02.016

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  55 in total

1.  A structural basis for varied αβ TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule.

Authors:  Stephanie Gras; Pascal G Wilmann; Zhenjun Chen; Hanim Halim; Yu Chih Liu; Lars Kjer-Nielsen; Anthony W Purcell; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity.

Authors:  Mikkel Harndahl; Michael Rasmussen; Gustav Roder; Ida Dalgaard Pedersen; Mikael Sørensen; Morten Nielsen; Søren Buus
Journal:  Eur J Immunol       Date:  2012-06       Impact factor: 5.532

3.  Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics.

Authors:  Oleg Y Borbulevych; Priscilla Do; Brian M Baker
Journal:  Mol Immunol       Date:  2010-07-08       Impact factor: 4.407

4.  Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics.

Authors:  Oleg Y Borbulevych; Kurt H Piepenbrink; Brian M Baker
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

5.  Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay.

Authors:  Mikkel Harndahl; Michael Rasmussen; Gustav Roder; Søren Buus
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

6.  Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.

Authors:  Andreas Schlundt; Sebastian Günther; Jana Sticht; Marek Wieczorek; Yvette Roske; Udo Heinemann; Christian Freund
Journal:  J Mol Biol       Date:  2012-07-20       Impact factor: 5.469

7.  Bidirectional binding of invariant chain peptides to an MHC class II molecule.

Authors:  Sebastian Günther; Andreas Schlundt; Jana Sticht; Yvette Roske; Udo Heinemann; Karl-Heinz Wiesmüller; Günther Jung; Kirsten Falk; Olaf Rötzschke; Christian Freund
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

8.  HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; Omar Dominguez-Amorocho; Lawrence J Stern
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

9.  Characterization of structural features controlling the receptiveness of empty class II MHC molecules.

Authors:  Bernd Rupp; Sebastian Günther; Talat Makhmoor; Andreas Schlundt; Katharina Dickhaut; Shashank Gupta; Iqbal Choudhary; Karl-Heinz Wiesmüller; Günther Jung; Christian Freund; Kirsten Falk; Olaf Rötzschke; Ronald Kühne
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

10.  T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.

Authors:  Julia Ekeruche-Makinde; Mathew Clement; David K Cole; Emily S J Edwards; Kristin Ladell; John J Miles; Katherine K Matthews; Anna Fuller; Katy A Lloyd; Florian Madura; Garry M Dolton; Johanne Pentier; Anna Lissina; Emma Gostick; Tiffany K Baxter; Brian M Baker; Pierre J Rizkallah; David A Price; Linda Wooldridge; Andrew K Sewell
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

View more
  23 in total

1.  Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.

Authors:  Behnoush Hajian; Eric Scocchera; Carolyn Shoen; Jolanta Krucinska; Kishore Viswanathan; Narendran G-Dayanandan; Heidi Erlandsen; Alexavier Estrada; Katarína Mikušová; Jana Korduláková; Michael Cynamon; Dennis Wright
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

2.  Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.

Authors:  Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

3.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

4.  Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity.

Authors:  Preeti Sharma; David M Kranz
Journal:  J Biol Chem       Date:  2017-12-11       Impact factor: 5.157

5.  High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity Predictions.

Authors:  Dylan T Blaha; Scott D Anderson; Daniel M Yoakum; Marlies V Hager; Yuanyuan Zha; Thomas F Gajewski; David M Kranz
Journal:  Cancer Immunol Res       Date:  2018-11-13       Impact factor: 11.151

6.  How an alloreactive T-cell receptor achieves peptide and MHC specificity.

Authors:  Yuan Wang; Nishant K Singh; Timothy T Spear; Lance M Hellman; Kurt H Piepenbrink; Rachel H McMahan; Hugo R Rosen; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-01       Impact factor: 11.205

7.  Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses.

Authors:  Michael E Birnbaum; Stephanie K Dougan; Eleanor Clancy-Thompson; Christine A Devlin; Paul M Tyler; Mariah M Servos; Lestat R Ali; Katherine S Ventre; M Aladdin Bhuiyan; Patrick T Bruck
Journal:  Cancer Immunol Res       Date:  2018-10-23       Impact factor: 11.151

8.  A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.

Authors:  George Mavridis; Richa Arya; Alexander Domnick; Jerome Zoidakis; Manousos Makridakis; Antonia Vlahou; Anastasia Mpakali; Angelos Lelis; Dimitris Georgiadis; Robert Tampé; Athanasios Papakyriakou; Lawrence J Stern; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

9.  Structural dissimilarity from self drives neoepitope escape from immune tolerance.

Authors:  Jason R Devlin; Jesus A Alonso; Cory M Ayres; Grant L J Keller; Sara Bobisse; Craig W Vander Kooi; George Coukos; David Gfeller; Alexandre Harari; Brian M Baker
Journal:  Nat Chem Biol       Date:  2020-08-17       Impact factor: 15.040

Review 10.  Protein aggregation and immunogenicity of biotherapeutics.

Authors:  Ngoc B Pham; Wilson S Meng
Journal:  Int J Pharm       Date:  2020-06-09       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.